US Patent 8778678 Composition of activated CD4 cells
Patent 8778678 was granted and assigned to Immunovative Therapies on July, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8778678 Composition of activated CD4 cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
